The value of a single biopsy with 12 transperineal cores for detecting prostate cancer in patients with elevated prostate specific antigen

Journal of Urology

Volumn 166, Issue 3, 2001, Pages 845-850

  Emiliozzi, P ^a   Longhi, S ^a   Scarpone, P ^a   Pansadoro, A ^a   DePaula, F ^a   Pansadoro, V ^a  

^a MOLINETTE HOSPITAL   (Italy)

Author keywords

Biopsy; Prostate; Prostate specific antigen; Prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BIOPSY TECHNIQUE; CANCER DIAGNOSIS; CANCER GRADING; CONTROLLED STUDY; HEMATURIA; HEMOSPERMIA; HUMAN; LOCAL ANESTHESIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE BIOPSY; PROSTATE CANCER; TRANSRECTAL ULTRASONOGRAPHY; URINE RETENTION;

EID: 0034879957     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)65849-1     Document Type: Article

References (48)

1. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate
2. Observations on pathology trends in 62,537 prostate biopsies obtained from urology private practices in the United States
3. Extended field prostate biopsy enhances cancer detection
4. Diagnostic value of additional systematic prostate biopsies in patients undergoing transurethral resection of the prostate
5. Use of repeat sextant and transition zone biopsies for assessing extent of prostate cancer
6. Computer modeling of prostate biopsy: Tumor size and location - Not clinical significance - Determine cancer detection
7. Single focus of adenocarcinoma in the prostate biopsy specimen is not predictive of the pathologic stage of disease
8. Diagnostic yield of repeated transrectal ultrasound-guided biopsies stratified by specific histopathologic diagnoses and prostate specific antigen levels
9. The significance of prior benign needle biopsies in men subsequently diagnosed with prostate cancer
10. Biopsy protocol stability in a three-dimensional model of prostate yield after adjustment of biopsy positions
11. Comparison of prostate biopsy schemes by computer simulation
12. Three-dimensional computer-simulated prostate models: Lateral prostate biopsies increase the detection rate of prostate cancer
13. A comparative analysis of sextant and an extended 11-core multisite directed biopsy strategy
14. Systematic 5 region biopsy is superior to sextant method for diagnosing carcinoma of the prostate
15. The optimal systematic prostate biopsy scheme should include 8 rather than 6 biopsies: Results of a prospective clinical trial
16. Extensive repeat transrectal ultrasound guided prostate biopsies in patients with previous benign sextant biopsies
17. Prostate-specific antigen (PSA), PSA density and age-adjusted PSA reference values in screening for prostate cancer: A study of a randomly selected population of 2,400 men
18. Clinical and pathologic tumor characteristics of prostate cancer as a function of the number of biopsy cores: A retrospective study
19. Strategy for repeat biopsy in patients with high grade prostatic intraepithelial neoplasia
20. Results of a prospective randomized study comparing 6, 12, and 18 trans-rectal, ultrasound guided, sextant biopsies in patients with elevated PSA, normal DRE and normal prostatic ultrasound
21. A model for the number of cores per prostate biopsy based on patient age and prostate gland volume
22. Outcome of sextant biopsy according to gland volume
23. Three-dimensional computer-assisted analysis of sector biopsy of the prostate
24. Variability in patient preparation for prostate biopsy among American urologists
25. Unsuspected adenocarcinoma of the prostate in patients undergoing cystoprostatectomy for other causes; incidence, histology and morphometric observations
26. Comparative study of two different TRUS-guided sextant biopsy techniques in detecting prostate cancer in one biopsy session
27. Value of systematic transition zone biopsies in the early detection of prostate cancer
28. Comparison of prostate specific antigen with prostate specific antigen density for 3 clinical applications
29. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: Results of a multicenter clinical trial of 6,630 men
30. Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen
31. Comparison of different prostate-specific antigen cutpoints for early detection of prostate cancer: Results of a large screening study
32. Ultrasonography of the prostate and biopsy
33. The free-to-total prostate specific antigen ratio improves the specificity of prostate specific antigen in screening for prostate cancer in the general population
34. The changing pattern of prostate cancer at the time of diagnosis: Characteristics of screen detected prostate cancer in a population based screening study
35. Diagnostic value of ten systematic TRUS-guided prostate biopsies
36. Screening for prostatic carcinoma with prostate-specific antigen
37. Prospective evaluation of prostate-specific antigen density and systematic biopsies for early detection of prostatic carcinoma
38. Early detection of prostate cancer in men with prostatism and intermediate prostate-specific antigen levels
39. Total and transition zone prostate volume and age: How do they affect the utility of PSA-based diagnostic parameters for early prostate cancer detection?
40. Pain and morbidity of transrectal ultrasound guided prostate biopsy: A prospective randomized trial of 6 versus 12 cores
41. Risks and complication of transrectal ultrasound guided prostate needle biopsy: A prospective study and review of the literature
42. Periprostatic local anesthesia before ultrasound guided prostate biopsy
43. Transrectal ultrasound guided prostatic nerve blockade eases systematic needle biopsy of the prostate
44. Prostate-specific antigen following anatomical retropubic prostatectomy. Patterns of recurrence and cancer control
45. Nonpalpable stage T1c prostate cancer: Prediction of insignificant disease using free/total prostate specific antigen levels and needle biopsy findings
46. Prostate specific antigen detected prostate cancer (clinical stage T1c): An interim analysis
47. Gleason score from prostate biopsies obtained with 18-gauge biopsy needles poorly predict Gleason scored of radical prostatectomy specimens
48. Long-term survival among men with conservatively treated localized prostate cancer